- Home
- GNFT vs LEGT Comparison
GNFT vs LEGT Comparison
Compare GNFT & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- LEGT
- Stock Information
- Founded
- GNFT 1999
- LEGT 2023
- Country
- GNFT France
- LEGT United States
- Employees
- GNFT N/A
- LEGT N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- LEGT
- Sector
- GNFT Health Care
- LEGT
- Exchange
- GNFT Nasdaq
- LEGT Nasdaq
- Market Cap
- GNFT 296.4M
- LEGT 265.3M
- IPO Year
- GNFT 2019
- LEGT 2024
- Fundamental
- Price
- GNFT $4.50
- LEGT $10.27
- Analyst Decision
- GNFT Strong Buy
- LEGT
- Analyst Count
- GNFT 1
- LEGT 0
- Target Price
- GNFT $13.00
- LEGT N/A
- AVG Volume (30 Days)
- GNFT 6.3K
- LEGT 54.3K
- Earning Date
- GNFT 09-19-2024
- LEGT 01-01-0001
- Dividend Yield
- GNFT N/A
- LEGT N/A
- EPS Growth
- GNFT N/A
- LEGT N/A
- EPS
- GNFT 0.47
- LEGT N/A
- Revenue
- GNFT $86,225,222.00
- LEGT N/A
- Revenue This Year
- GNFT $155.44
- LEGT N/A
- Revenue Next Year
- GNFT N/A
- LEGT N/A
- P/E Ratio
- GNFT $9.31
- LEGT N/A
- Revenue Growth
- GNFT 175.45
- LEGT N/A
- 52 Week Low
- GNFT $3.08
- LEGT $10.00
- 52 Week High
- GNFT $6.42
- LEGT $10.47
- Technical
- Relative Strength Index (RSI)
- GNFT 28.81
- LEGT N/A
- Support Level
- GNFT $5.10
- LEGT N/A
- Resistance Level
- GNFT $5.81
- LEGT N/A
- Average True Range (ATR)
- GNFT 0.21
- LEGT 0.00
- MACD
- GNFT -0.16
- LEGT 0.00
- Stochastic Oscillator
- GNFT 6.13
- LEGT 0.00
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.